BioXcel Therapeutics Announces BXCL501 Program Initiative for Prevention and Treatment of Acute Agitation using Wearable Digital Devices Read more
Poxel Initiates Phase 1b Multiple Ascending Dose (MAD) Trial for NASH Drug Candidate, PXL065 Read more
Concert Pharmaceuticals completes enrollment in second open label trial of CTP-543 in alopecia areata Read more
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis Read more
FDA Accepts Merck’s BLA and Grants Priority Review for V920, the Company’s Investigational Vaccine for Ebola Zaire Virus Read more
Exclusive interview with Novartis industry leader, Maxime Gaillot, for the Wearable Injectors and Connected Devices conference 2019 in London Read more